$CTXR 3.29 had $10m net assets (last 10Q) just funded for more $26.8m. vs $25m MC and Dec. 2017 FDA Catalysts. P2 & P3 the Chairman, invested $1.7M recently. loading. way undervalued relating Equity and Market Potential (As described in yesterday's Letter to Shareholders).very recommended at current price.
this Article posted before upgraded to NASDAQ and letter to shareholders:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.